MIRXES-B Announces Board Changes: New Independent Director Takes Office

Stock News09-01

MIRXES-B (02629) has announced a series of board changes. Dr. Lam Chan Lai has resigned from her roles as Independent Non-Executive Director, Chairman of the Audit Committee, member of the Remuneration Committee, member of the Nomination Committee, and Chairman of the Independent Investigation Committee, effective August 31, 2026, citing health reasons.

The board accepted Dr. Lam's resignation on the same date, August 31, 2026. To fill the resulting temporary vacancy, Mr. Chou Siu Wing has been appointed as an Independent Non-Executive Director, effective immediately on August 31, 2026.

Concurrent with his appointment, Mr. Chou has also been designated as Chairman of the Nomination Committee, a member of the Remuneration Committee, and Co-Chairman of the Independent Investigation Committee, all taking effect immediately.

Furthermore, on August 31, 2026, the board resolved to make the following appointments, all effective immediately: Mr. Tsang Kwok Wai as Chairman of the Audit Committee; Mr. Fang Xiao and Mr. Chou as Co-Chairmen of the Independent Investigation Committee; Mr. Chou as Chairman of the Nomination Committee; and Mr. Chou as a member of the Remuneration Committee.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112001279?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-01 08:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112001279","market":"nz","top_or_hot":-1,"title":"MIRXES-B Announces Board Changes: New Independent Director Takes Office","media":"Stock News","content":"<p>MIRXES-B (02629) has announced a series of board changes. Dr. Lam Chan Lai has resigned from her roles as Independent Non-Executive Director, Chairman of the Audit Committee, member of the Remuneration Committee, member of the Nomination Committee, and Chairman of the Independent Investigation Committee, effective August 31, 2026, citing health reasons.<br><br>The board accepted Dr. Lam's resignation on the same date, August 31, 2026. To fill the resulting temporary vacancy, Mr. Chou Siu Wing has been appointed as an Independent Non-Executive Director, effective immediately on August 31, 2026.<br><br>Concurrent with his appointment, Mr. Chou has also been designated as Chairman of the Nomination Committee, a member of the Remuneration Committee, and Co-Chairman of the Independent Investigation Committee, all taking effect immediately.<br><br>Furthermore, on August 31, 2026, the board resolved to make the following appointments, all effective immediately: Mr. Tsang Kwok Wai as Chairman of the Audit Committee; Mr. Fang Xiao and Mr. Chou as Co-Chairmen of the Independent Investigation Committee; Mr. Chou as Chairman of the Nomination Committee; and Mr. Chou as a member of the Remuneration Committee.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MIRXES-B Announces Board Changes: New Independent Director Takes Office</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMIRXES-B Announces Board Changes: New Independent Director Takes Office\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-01 08:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MIRXES-B (02629) has announced a series of board changes. Dr. Lam Chan Lai has resigned from her roles as Independent Non-Executive Director, Chairman of the Audit Committee, member of the Remuneration Committee, member of the Nomination Committee, and Chairman of the Independent Investigation Committee, effective August 31, 2026, citing health reasons.<br><br>The board accepted Dr. Lam's resignation on the same date, August 31, 2026. To fill the resulting temporary vacancy, Mr. Chou Siu Wing has been appointed as an Independent Non-Executive Director, effective immediately on August 31, 2026.<br><br>Concurrent with his appointment, Mr. Chou has also been designated as Chairman of the Nomination Committee, a member of the Remuneration Committee, and Co-Chairman of the Independent Investigation Committee, all taking effect immediately.<br><br>Furthermore, on August 31, 2026, the board resolved to make the following appointments, all effective immediately: Mr. Tsang Kwok Wai as Chairman of the Audit Committee; Mr. Fang Xiao and Mr. Chou as Co-Chairmen of the Independent Investigation Committee; Mr. Chou as Chairman of the Nomination Committee; and Mr. Chou as a member of the Remuneration Committee.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1112001279","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112001279","pubTimestamp":1788221182,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"MIRXES-B (02629) has announced a series of board changes. Dr. Lam Chan Lai has resigned from her roles as Independent Non-Executive Director, Chairman of the Audit Committee, member of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02629":"MIRXES-B"},"translate_title":"MIRXES-B 宣布董事会变动：新独立董事上任","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02629":1},"content_text":"MIRXES-B (02629) has announced a series of board changes. Dr. Lam Chan Lai has resigned from her roles as Independent Non-Executive Director, Chairman of the Audit Committee, member of the Remuneration Committee, member of the Nomination Committee, and Chairman of the Independent Investigation Committee, effective August 31, 2026, citing health reasons.The board accepted Dr. Lam's resignation on the same date, August 31, 2026. To fill the resulting temporary vacancy, Mr. Chou Siu Wing has been appointed as an Independent Non-Executive Director, effective immediately on August 31, 2026.Concurrent with his appointment, Mr. Chou has also been designated as Chairman of the Nomination Committee, a member of the Remuneration Committee, and Co-Chairman of the Independent Investigation Committee, all taking effect immediately.Furthermore, on August 31, 2026, the board resolved to make the following appointments, all effective immediately: Mr. Tsang Kwok Wai as Chairman of the Audit Committee; Mr. Fang Xiao and Mr. Chou as Co-Chairmen of the Independent Investigation Committee; Mr. Chou as Chairman of the Nomination Committee; and Mr. Chou as a member of the Remuneration Committee.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112001279","isCrawlerRequest":true}